Escalon Medical Corp. (ESMC)
USD 0.21
(6.06%)
USD 0.21
(6.06%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -602.77 Thousand | 325.14 Thousand | -1.04 Million | 838.7 Thousand | -168.49 Thousand | -472.68 Thousand |
| Net Income | -125.26 Thousand | 456.82 Thousand | 18.08 Thousand | -52.02 Thousand | -650.28 Thousand | -250.01 Thousand |
| Depreciation & Amortization | 46.01 Thousand | 45.2 Thousand | 48.43 Thousand | 44.81 Thousand | 50.08 Thousand | 50.13 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -810.11 Thousand | -644.43 Thousand | -1.04 Million | 561.3 Thousand | 230.65 Thousand | -267.36 Thousand |
| Other non-cash items | 303.65 Thousand | 467.55 Thousand | -71.31 Thousand | 284.61 Thousand | 201.05 Thousand | -5450.00 |
| Investing Cash Flow | -40.28 Thousand | -13.84 Thousand | - | -9390.00 | -59.75 Thousand | -22.11 Thousand |
| Investments in PPE | -40.28 Thousand | -13.84 Thousand | - | -9390.00 | -59.75 Thousand | -22.11 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -40.28 Million | -7155.00 | - | -9.39 Million | -59.75 Million | -22.11 Million |
| Financing Cash Flow | -37.45 Thousand | -15.37 Thousand | -6931.00 | -3664.00 | 646.6 Thousand | 33.68 Thousand |
| Debt repayment | -37.45 Thousand | -15.37 Thousand | -6931.00 | -3664.00 | -3393.00 | -2893.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -37.45 Million | -15.37 Thousand | -6931.00 | -3664.00 | 650 Thousand | 36.57 Thousand |
| Accounts receivables | -454.01 Thousand | -229.97 Thousand | -615.31 Thousand | 221.23 Thousand | 171.16 Thousand | -103.52 Thousand |
| Accounts payables | 151.71 Thousand | 193.05 Thousand | -89.67 Thousand | 341.5 Thousand | 94.11 Thousand | 137.66 Thousand |
| Inventory | -24.47 Thousand | -44.03 Thousand | -187.22 Thousand | 368.3 Thousand | 93.83 Thousand | -55.44 Thousand |
| Other working capital | -146.22 Thousand | -563.49 Thousand | -152.9 Thousand | -369.73 Thousand | -128.45 Thousand | -246.06 Thousand |
| Cash at beginning of period | 1.14 Million | 850.03 Thousand | 1.9 Million | 1.08 Million | 662.87 Thousand | 1.12 Million |
| Cash at end of period | 465.45 Thousand | 1.14 Million | 850.03 Thousand | 1.9 Million | 1.08 Million | 662.87 Thousand |
| Capital Expenditure | -40.28 Thousand | -13.84 Thousand | - | -9390.00 | -59.75 Thousand | -22.11 Thousand |
| Effect of forex changes on cash | - | 295.63 Million | - | - | - | - |
| Net cash flow / Change in cash | -680.51 Thousand | 295.93 Thousand | -1.05 Million | 825.65 Thousand | 418.36 Thousand | -461.12 Thousand |
| Free Cash Flow | -643.05 Thousand | 311.3 Thousand | -1.04 Million | 829.31 Thousand | -228.24 Thousand | -494.8 Thousand |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 134.4 Thousand | -162.14 Thousand | -76.32 Thousand | -21.19 Thousand | 198.35 Thousand | 456.82 Thousand |
| Depreciation & Amortization | 19.25 Thousand | 3583.00 | 162.8 Thousand | 11.02 Thousand | 10.77 Thousand | 45.2 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -532.2 Thousand | 256.85 Thousand | -374.44 Thousand | 149.75 Thousand | -199.39 Thousand | -644.43 Thousand |
| Other non-cash items | 76.1 Thousand | -194.05 Thousand | -34.16 Thousand | -255.54 Thousand | 345.18 Thousand | 467.55 Thousand |
| Investing Cash Flow | -9247.00 | 9248.00 | -21.95 Thousand | -18.32 Thousand | -13.82 Million | -13.84 Thousand |
| Investments in PPE | -9247.00 | 9248.00 | -21.95 Thousand | -18.32 Thousand | 13.84 Thousand | -13.84 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -18.32 Million | -13.83 Million | -7155.00 |
| Financing Cash Flow | -6524.00 | -10.14 Thousand | -10.27 Thousand | -10.52 Thousand | -9520.00 | -15.37 Thousand |
| Debt repayment | -6524.00 | -10.14 Thousand | -10.27 Thousand | -10.52 Thousand | -9520.00 | -15.37 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -10.52 Million | -9520.00 | -15.37 Thousand |
| Accounts receivables | -728.18 Thousand | 544.95 Thousand | -428.71 Thousand | 157.92 Thousand | -122.39 Thousand | -229.97 Thousand |
| Accounts payables | 239.16 Thousand | 130.54 Thousand | -140.7 Thousand | -77.29 Thousand | 157.68 Thousand | 193.05 Thousand |
| Inventory | 192.46 Thousand | -397.38 Thousand | 111.32 Thousand | 69.12 Thousand | 17.2 Thousand | -44.03 Thousand |
| Other working capital | -123.06 Thousand | -21.26 Thousand | 83.65 Thousand | -149.75 Thousand | -251.88 Thousand | -563.49 Thousand |
| Cash at beginning of period | 821.09 Thousand | 646.79 Thousand | 1 Million | 1.14 Million | 800.56 Thousand | 850.03 Thousand |
| Cash at end of period | 465.45 Thousand | 821.09 Thousand | 646.79 Thousand | 1 Million | 1.14 Million | 1.14 Million |
| Capital Expenditure | -9247.00 | 9248.00 | -21.95 Thousand | -18.32 Thousand | 13.84 Thousand | -13.84 Thousand |
| Effect of forex changes on cash | - | - | - | - | -7147.85 | 295.63 Million |
| Net cash flow / Change in cash | -355.64 Thousand | 174.29 Thousand | -354.35 Thousand | -144.81 Thousand | 345.4 Thousand | 295.93 Thousand |
| Free Cash Flow | -349.11 Thousand | 184.43 Thousand | -344.08 Thousand | -134.29 Thousand | 368.76 Thousand | 311.3 Thousand |
IVDN
ARB
MGM
CHFHF
9812
ALNRG